{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:05:41Z","timestamp":1768806341498,"version":"3.49.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1016\/s0002-8703(96)90465-2","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T09:46:44Z","timestamp":1094032004000},"page":"1207-1221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["The placebo effect in cardiovascular disease"],"prefix":"10.1016","volume":"132","author":[{"given":"Laura","family":"Bienenfeld","sequence":"first","affiliation":[]},{"given":"William","family":"Frishman","sequence":"additional","affiliation":[]},{"given":"Stephen P.","family":"Glasser","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0002-8703(96)90465-2_BIB1","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.1994.03510440069036","article-title":"The importance placebo effects in pain treatment and research","volume":"271","author":"Turner","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.1975.03250120013012","article-title":"The placebo effect, a neglected asset in the care of patients","volume":"232","author":"Benson","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.CIR.71.4.761","article-title":"Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure","volume":"71","author":"Packer","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB4","series-title":"Melmon and Morrelli's clinical pharmacology: basic principles in therapeutics","first-page":"896","year":"1992"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM196804182781615","article-title":"Prophylactic treatment of Wilson's disease","volume":"278","author":"Chalmers","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB6","series-title":"History of medicine","author":"Garrison","year":"1929"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB7","first-page":"1371","year":"1990"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB8","first-page":"18","article-title":"Doctors, Patients and placebos","author":"Spiro","year":"1986"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB9","series-title":"Placebo: theory, research, and mechanisms","first-page":"9","year":"1985"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1176\/appi.psychotherapy.1964.18.s1.73","article-title":"Factors contributing to the placebo effect: their implications for psychotherapy","volume":"18","author":"Shapiro","year":"1961","journal-title":"Am J Psychother"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1353\/pbm.1976.0038","article-title":"Explaining and exploiting placebo effects","volume":"19","author":"Byerly","year":"1976","journal-title":"Pers Biol Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB12","series-title":"A treatise of the scurvy","author":"Lind","year":"1753"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/oxfordjournals.bmb.a073919","article-title":"The clinical trial","volume":"7","author":"Hill","year":"1951","journal-title":"Br Med Bull"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB14","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.1955.02960340022006","article-title":"The powerful placebo","volume":"159","author":"Beecher","year":"1955","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/0002-9343(54)90441-6","article-title":"A study of the placebo response","volume":"16","author":"Lasagna","year":"1954","journal-title":"Am J Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jama.1954.03690220013004","article-title":"Effects of placebo administration and occurrence of toxic reactions","volume":"155","author":"Wolf","year":"1954","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/00325481.1990.11704748","article-title":"Don't let placebos fool you","volume":"88","author":"Davis","year":"1990","journal-title":"Postgrad Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB18","series-title":"Goodman and Gilman's The pharmacological basis of therapeutics","first-page":"55","article-title":"Principles of therapeutics","author":"Nies","year":"1996"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB19","first-page":"1","article-title":"Dilemmas in the use of active control groups in clinical research","volume":"11","author":"Makuch","year":"1989","journal-title":"IRBA Review of Human Subjects Research"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB20","series-title":"Draft guidelines for the clinical evaluation of anti-anginal drugs","author":"Food and Drug Administration","year":"1989"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB21","first-page":"31","article-title":"Magic or medicine? clinical pharmacological basis of placebo medication","volume":"20","author":"Oh","year":"1991","journal-title":"Ann Acad Med (Singapore)"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB22","series-title":"Principles of neural science","first-page":"276","article-title":"Anatomical organization of the nervous system","author":"Kelly","year":"1991"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3959(90)90057-K","article-title":"The role of conditioning and verbal expectancy in the placebo response","volume":"43","author":"Voudouris","year":"1990","journal-title":"Pain"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB24","first-page":"3528","article-title":"Role of pain in placebo analgesia","volume":"76","author":"Levine","year":"1979"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0030-4220(93)90219-T","article-title":"Narcotic receptor blockade and its effect on the analgesic response to placebo and ibuprofen after oral surgery","volume":"75","author":"Hersh","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0306-9877(88)90003-5","article-title":"The mechanism of the psychophysiological effects of placebo","volume":"27","author":"Kojo","year":"1988","journal-title":"Med Hypothes"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM196404162701606","article-title":"Reduction of post-operative pain by encouragement and instruction of patients","volume":"270","author":"Egbert","year":"1964","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-9149(69)90422-6","article-title":"New aspects of the placebo response in angina pectoris","volume":"24","author":"Amsterdam","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB29","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.1991.03460120064037","article-title":"Exposing patients with chronic, stable, exertional angina to placebo periods in drug trials","volume":"265","author":"Glasser","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB30","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/oxfordjournals.eurheartj.a062012","article-title":"Time course of long-term placebo therapy effects in angina pectoris","volume":"7","author":"Boissel","year":"1986","journal-title":"Eur Heart J"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/clpt.1981.167","article-title":"Variability of exercise performance during long-term placebo treatment","volume":"30","author":"McGraw","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB32","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0002-9149(91)90229-E","article-title":"Acute and chronic antianginal efficacy and continuous 24 hour application of transdermal nitroglycerin","volume":"68","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB33","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jama.1961.63040260007008","article-title":"Surgery as a placebo: a quantitative study in bias","volume":"176","author":"Beecher","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB34","first-page":"712","article-title":"Evaluation of internal mammary artery ligation and sham procedures in angina pectoris","volume":"18","author":"Dimond","year":"1958","journal-title":"Circulation"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0002-9149(60)90105-3","article-title":"Comparison of internal mammary artery ligation and sham operation for angina pectoris","volume":"5","author":"Dimond","year":"1960","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM195905282602204","article-title":"Evaluation of internal mammary artery ligation by double-blind technic","volume":"260","author":"Cobb","year":"1959","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB37","first-page":"81","article-title":"Sham therapy in coronary artery disease and atherosclerosis","volume":"14","author":"Carver","year":"1988","journal-title":"Pract Cardiol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB38","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.90.3.1194","article-title":"Chelation therapy for intermittent claudication","volume":"90","author":"van Rij","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB39","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0002-8703(90)90062-3","article-title":"The placebo effect in heart failure","volume":"120","author":"Packer","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000175787","article-title":"Placebo treatment in congestive heart failure","volume":"81","author":"Archer","year":"1992","journal-title":"Cardiology"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/cpt1976195part1502","article-title":"Atenolol in essential hypertension","volume":"19","author":"Myers","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/cpt196785676","article-title":"An analysis of the placebo effect in hospitalized hypertensive patients","volume":"8","author":"Moutsos","year":"1967","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2125.1979.tb00898.x","article-title":"A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension","volume":"7","author":"Pugsley","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2125.1978.tb00863.x","article-title":"Acebutolol in hypertension: a double-blind trial against placebo","volume":"6","author":"Martin","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB45","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/bmj.1.6074.1437","article-title":"Randomized controlled trial of treatment for mild hypertension: design and pilot trial","volume":"1","author":"Medical Research Council Working Party on Mild to Moderate Hypertension","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB46","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(81)92799-9","article-title":"Does placebo lower blood pressure?","volume":"2","author":"Gould","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archinte.1960.03820010083013","article-title":"A double-blind control study of antihypertensive agents: I. comparative effectiveness of reserpine, reserpine and hydralazine and three ganglionic blocking agents, chlorisondamine, mecamyamine and pentolinium tartrate","volume":"106","year":"1960","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2125.1977.tb00714.x","article-title":"A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension","volume":"4","author":"Wilkinson","year":"1977","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/bmj.2.5967.367","article-title":"Controlled study of atenolol in treatment of hypertension","volume":"2","author":"Hanson","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB50","first-page":"116","article-title":"Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 119 mmHg","volume":"202","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB51","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1970.03170330025003","article-title":"Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 90 through 114 mmHg","volume":"213","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB52","unstructured":"Reference deleted in proof."},{"key":"10.1016\/S0002-8703(96)90465-2_BIB53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/01.CIR.14.2.260","article-title":"Reassurance in the management of benign hypertensive disease","volume":"14","author":"Goldring","year":"1956","journal-title":"Circulation"},{"issue":"Suppl 6","key":"10.1016\/S0002-8703(96)90465-2_BIB54","first-page":"S93","article-title":"The effect of placebo on indirect and direct blood pressure measurements","volume":"8","author":"Raftery","year":"1990","journal-title":"J Hypertens"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00004872-199104000-00008","article-title":"Effect of placebo on 24 h non-invasive ambulatory blood pressure","volume":"9","author":"Mutti","year":"1991","journal-title":"J Hypertens"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB56","first-page":"243","article-title":"Ambulatory blood pressure measurements in the evaluation of blood pressure lowering drugs","volume":"7","author":"O'Brien","year":"1989","journal-title":"J Hypertens"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB57","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2125.1987.tb03145.x","article-title":"Placebo does not lower ambulatory blood pressure","volume":"24","author":"Dupont","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00148475","article-title":"Ambulatory blood pressure monitoring in the assessment of antihypertensive therapy","volume":"3","author":"Coats","year":"1989","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB59","doi-asserted-by":"crossref","first-page":"27C","DOI":"10.1016\/0002-9149(88)90481-X","article-title":"Evaluation of the antihypertensive effect of celiprolol by ambulatory blood pressure monitoring","volume":"61","author":"Parati","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB60","first-page":"797","article-title":"Twenty-four hour blood pressure monitoring: evaluation of Spacelabs 5300 monitor by comparison with intra-arterial blood pressure recording in ambulant subjects","volume":"6","author":"Casadei","year":"1988","journal-title":"J Hypertens"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1536\/ihj.29.189","article-title":"Does placebo lower blood pressure in hypertensive patients? a noninvasive chronobiological study","volume":"29","author":"Portaluppi","year":"1988","journal-title":"Jpn Heart J"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB62","first-page":"304","article-title":"Influence of observer's expectation on the placebo effect in blood pressure trials","volume":"41","author":"Sassano","year":"1987","journal-title":"Curr Ther Res"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB63","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB64","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0197-2456(93)90051-E","article-title":"Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP)","volume":"14","author":"Davis","year":"1993","journal-title":"Controlled Clin Trials"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB65","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.CIR.61.4.690","article-title":"Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording","volume":"61","author":"Michelson","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0002-9149(87)80078-4","article-title":"Application of a frequency definition of ventricular proarrhythmia","volume":"59","author":"Morganroth","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB67","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB68","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/0735-1097(91)90671-U","article-title":"Events in the Cardiac Arrhythmia Suppression Trial: baseline predictors of mortality in placebo-treated patients","volume":"18","author":"Capone","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB69","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM198010303031804","article-title":"Influence of adherence to treatment and response to cholesterol on mortality in the Coronary Drug Project","volume":"303","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB70","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0140-6736(90)92095-Y","article-title":"Treatment adherence and risk of death after a myocardial infarction","volume":"336","author":"Horwitz","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB71","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jama.1993.03510060088038","article-title":"The relationship of treatment adherence to the risk of death after myocardial infarction in women","volume":"270","author":"Gallagher","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB72","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1984.03340270043026","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results: II. the relationship of reduction in incidence of coronary heart disease to cholesterol lowering","volume":"251","author":"Lipid Research Clinics Program","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB73","first-page":"35","article-title":"The problem of compliance with antihypertensive therapy","volume":"2","author":"Sackett","year":"1976","journal-title":"Pract Cardiol"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB74","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1001\/archinte.1994.00420230032005","article-title":"Adherence to aspirin in the prevention of myocardial infarction","volume":"154","author":"Glynn","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB75","first-page":"1","article-title":"Dilemmas in the use of active control groups in clinical research","volume":"11","author":"Makuch","year":"1989","journal-title":"IRB Rev Hum Subj Res"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB76","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199408113310611","article-title":"The continuing unethical use of placebo controls [sounding board]","volume":"331","author":"Rothman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB77","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJM199501053320114","article-title":"Use of placebo controls","volume":"332","author":"Schechter","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB78","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-119-4-199308150-00013","article-title":"Blood pressure management: individualized treatment based on absolute risk and the potential for benefit","volume":"119","author":"Alderman","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB79","first-page":"35","article-title":"The powerful placebo revisited: magnitude of nonspecific effects","volume":"1","author":"Roberts","year":"1995","journal-title":"Mind\/Body Medicine"},{"key":"10.1016\/S0002-8703(96)90465-2_BIB80","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2125.1995.tb04434.x","article-title":"Influence of the behaviour pattern on the nocebo response of healthy volunteers","volume":"39","author":"Drici","year":"1995","journal-title":"Br J Clin Pharmacol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870396904652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870396904652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:09:14Z","timestamp":1757567354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870396904652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["S0002870396904652"],"URL":"https:\/\/doi.org\/10.1016\/s0002-8703(96)90465-2","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[1996,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The placebo effect in cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-8703(96)90465-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}